Electronic cigarette oil brand Bantam announced today that its pre-market tobacco product application (PMTA) for non-tobacco nicotine electronic cigarette oil has been accepted by the US Food and Drug Administration (FDA). The brand's application now enters the next stage of the PMTA process - preliminary scientific review, to confirm that the application contains all necessary items and allow for substantive review by the FDA.
On May 13, 2022, Bantam Company submitted an application to the FDA for its non-tobacco nicotine e-cigarette oil and is seeking marketing authorization from the agency.
We have received this acceptance letter, which reflects Bantam's effort to provide high-quality, science-based electronic liquids for adult consumers while also adhering to our responsibility to restrict youth access and use of these products," said Anthony Dillon, Bantam spokesperson. "Bantam continues to support the need for scientific regulation of the electronic liquid industry and is proud of our various PMTA progress. We remain confident in the quality, consistency, and scientific backing of our products.
Prior to submitting an application focused on non-tobacco nicotine, Bantam submitted a PMTA for its tobacco-derived e-liquid to the FDA in September 2020. The application entered scientific review in August 2021 and is still under FDA review.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
